Left atrial appendage occlusion and ligation devices: what is available, how to implement them, and how to manage and...

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Atrial fibrillation (AF) is a common arrhythmia linked to a high risk of stroke, often caused by clots in the left atrial appendage (LAA).
• LAA thrombi are implicated in over 90% of embolic events in AF patients.
• Surgical LAA ligation or excision is standard during mitral valve surgery or Maze procedures for AF.

Purpose of the Study:

• To review current strategies for left atrial appendage (LAA) exclusion in atrial fibrillation (AF) patients.
• To evaluate the efficacy and safety of LAA exclusion as an alternative to oral anticoagulation (OAC) for stroke prevention.
• To identify the need for further research on LAA occlusion and ligation techniques.

Main Methods:

• Review of existing literature on surgical and percutaneous LAA exclusion methods.
• Analysis of current evidence regarding the effectiveness of LAA ligation and occlusion devices.
• Discussion of LAA exclusion in the context of OAC contraindications and post-catheter ablation management.

Main Results:

• LAA exclusion, including surgical ligation, amputation, and percutaneous device closure, offers stroke protection in selected AF patients, particularly those with OAC contraindications.
• Percutaneous LAA closure and ligation studies show promising short-term results.
• Long-term efficacy and safety data for percutaneous LAA exclusion are currently insufficient for broad recommendation.

Conclusions:

• LAA exclusion is a reasonable option for stroke prevention in AF patients with contraindications to OAC.
• Further randomized trials are necessary to establish the long-term safety and efficacy of percutaneous LAA occlusion and ligation.
• The role of LAA occlusion/ligation in patients with successful AF catheter ablation requires further investigation, as antiplatelet therapy may suffice.